A team recognized for its design expertise which reaps the benefit from a 30-year experience and an active collaboration with an international academic network.
A centralized full-service with stand-alone departments specialized in clinical design, regulatory affairs, project management, adaptive monitoring, biostatistics, pharmacovigilance and medical writing.
A leadership in clinical R&D, whether the chosen methodology is traditional, adaptive frequentist or bayesian and whatever the stage of development (phases I, II, III).
ICTA’s hallmark in pharmacoepidemiology and pharmacoeconomics. A very professional pharmacovigilance department.
An evolution which entails the design of clinical studies focused on cost / efficiency and the use of modern biostatistic methodologies
A risk-based management based on the proactive identification of risk and the implementation of a continuous responsive management.
Consultancy in clinical development. Design and management of clinical studies specific to each medical device. Economic studies and Bayesian analyses.
Partner of choice for your Early and Compassionate Use programs
